ZNTL
Zentalis Pharmaceuticals, Inc.$2.60+0.04 (+1.56%)Prev Close$2.56·MCap$180.3M·P/E—·Vol68.3K·Yield—
▲
Buys (12M)
2
$7.78M
▼
Sells (12M)
8
$262.9K
◆
Net Activity
Net Buyer
$7.52M
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at Zentalis Pharmaceuticals, Inc. (ZNTL) has been dominated by buying, with 2 insider purchases totaling $7.78M and 8 insider sales totaling $262.9K. The most recent insider transaction was by Bruns Ingmar (officer: Chief Medical Officer), who sold $8.0K worth of shares on Feb 10, 2026. Zentalis Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $180.3M.
ZNTL Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Bruns Ingmar | officer: Chief Medical Officer | Sell | 3,297 | $2.43 | $8.0K | 33,667 |
| Feb 10, 2026 | EASTLAND JULIA MARIE | director, officer: CEO & President | Sell | 8,755 | $2.43 | $21.2K | 80,022 |
| Feb 10, 2026 | Vultaggio Vincent | officer: PAO and PFO | Sell | 40,224 | $2.43 | $97.6K | 156,779 |
| Feb 6, 2026 | Bruns Ingmar | Chief Medical Officer | Sell | 3,297 | $2.43 | $8.0K | 0 |
| Feb 6, 2026 | EASTLAND JULIA MARIE | CEO & President | Sell | 8,755 | $2.43 | $21.2K | 0 |
| Feb 6, 2026 | Vultaggio Vincent | PAO and PFO | Sell | 40,224 | $2.43 | $97.6K | 0 |
| Feb 4, 2026 | Vultaggio Vincent | officer: PAO and PFO | Sell | 556 | $2.52 | $1.4K | 186,730 |
| Feb 2, 2026 | Vultaggio Vincent | PAO and PFO | Sell | 3,096 | $2.54 | $7.9K | 0 |
| Dec 31, 2025 | WALTERS GROUP | 10% Owner | Buy | 6,459,973 | $1.20 | $7.75M | 0 |
| Apr 30, 2025 | Myers Scott Dunseth | Director | Buy | 21,000 | $1.40 | $29.4K | 0 |
| Feb 12, 2025 | Bruns Ingmar | Chief Medical Officer | Buy | 20,000 | $2.28 | $45.7K | 36,629 |
| Feb 5, 2025 | Lackner Mark | Chief Scientific Officer | Sell | 14,368 | $1.71 | $24.6K | 512,856 |
| Feb 5, 2025 | Paul Andrea | Chief Legal Officer | Sell | 13,230 | $1.71 | $22.6K | 1,070,784 |
| Feb 5, 2025 | Vultaggio Vincent | PAO and Interim PFO | Sell | 2,615 | $1.71 | $4.5K | 189,826 |
| Feb 4, 2025 | EASTLAND JULIA MARIE | CEO & President | Buy | 28,500 | $1.73 | $49.3K | 28,500 |
| Feb 4, 2025 | Skvarka Jan | Director | Buy | 60,000 | $1.72 | $103.4K | 149,551 |
| Feb 4, 2025 | Walker Luke Nathaniel | Director | Buy | 14,200 | $1.76 | $25.0K | 86,681 |
| Jan 3, 2025 | Lackner Mark | Chief Scientific Officer | Sell | 4,411 | $3.12 | $13.8K | 191,317 |
| Oct 4, 2024 | Vultaggio Vincent | Principal Accounting Officer | Sell | 1,603 | $3.18 | $5.1K | 33,855 |
| May 31, 2024 | Gallagher Cam | President, Interim CFO | Sell | 9,597 | $11.98 | $115.0K | 633,680 |
| May 9, 2024 | HAUSMAN DIANA | Chief Medical Officer | Sell | 3,356 | $12.62 | $42.4K | 373,876 |
| Feb 12, 2024 | Epperly Melissa B, | Chief Financial Officer | Sell | 2,573 | $11.44 | $29.4K | 451,449 |
| Feb 12, 2024 | Gallagher Cam | President | Sell | 1,173 | $11.44 | $13.4K | 643,277 |
| Feb 5, 2024 | Epperly Melissa B, | Chief Financial Officer | Sell | 8,669 | $11.54 | $100.0K | 454,022 |
| Feb 5, 2024 | Gallagher Cam | President | Sell | 11,552 | $11.54 | $133.3K | 644,450 |
| Feb 5, 2024 | Lackner Mark | Chief Scientific Officer | Sell | 1,585 | $11.54 | $18.3K | 195,728 |
| Feb 5, 2024 | Paul Andrea | Chief Legal Officer | Sell | 3,310 | $11.54 | $38.2K | 149,973 |
| Nov 13, 2023 | Blackwell Kimberly | Chief Executive Officer | Buy | 5,000 | $10.29 | $51.4K | 254,800 |
| Nov 13, 2023 | Johnson David Michael | Director | Buy | 17,000 | $9.88 | $167.9K | 144,389 |
| Oct 6, 2023 | Brownstein Carrie | Chief Medical Officer | Sell | 10,628 | $19.50 | $207.3K | 107,407 |
| Oct 6, 2023 | Bunker Kevin D. | Chief Scientific Officer | Sell | 6,068 | $19.50 | $118.4K | 860,072 |
| Oct 6, 2023 | Epperly Melissa B, | Chief Financial Officer | Sell | 5,482 | $19.50 | $106.9K | 388,579 |
| Sep 13, 2023 | Skvarka Jan | Director | Sell | 5,000 | $25.05 | $125.2K | 47,970 |
| Jun 20, 2023 | Matrix Capital Management Company, LP | 10% Owner | Buy | 4,760,000 | $22.66 | $107.86M | 13,959,973 |
| May 31, 2023 | Bunker Kevin D. | Chief Scientific Officer | Sell | 80,000 | $30.02 | $2.40M | 15,000 |
| May 31, 2023 | Gallagher Cam | President | Sell | 27,768 | $26.27 | $729.5K | 482,028 |
| Feb 14, 2023 | Bunker Kevin D. | Chief Scientific Officer | Sell | 10,307 | $20.14 | $207.6K | 871,657 |
| Feb 14, 2023 | Epperly Melissa B, | Chief Financial Officer | Sell | 7,851 | $20.13 | $158.0K | 397,275 |
| Feb 14, 2023 | Gallagher Cam | President | Sell | 11,833 | $20.09 | $237.8K | 499,771 |
| Feb 6, 2023 | Gallagher Cam | President | Sell | 10,000 | $22.27 | $222.7K | 503,675 |
| Jan 18, 2023 | Gallagher Cam | President | Sell | 10,000 | $24.15 | $241.5K | 352,511 |
| Jan 5, 2023 | Gallagher Cam | President | Sell | 10,000 | $21.02 | $210.2K | 362,311 |
| Nov 15, 2022 | Gallagher Cam | President | Sell | 12,500 | $22.77 | $284.7K | 372,911 |
| Nov 8, 2022 | Gallagher Cam | President | Sell | 24,874 | $23.62 | $587.4K | 397,042 |
| Oct 17, 2022 | Gallagher Cam | President | Sell | 12,500 | $23.51 | $293.9K | 409,385 |
| Oct 7, 2022 | Gallagher Cam | President | Sell | 22,500 | $22.45 | $505.2K | 437,381 |
| Sep 16, 2022 | Gallagher Cam | President | Sell | 22,500 | $24.90 | $560.3K | 458,459 |
| Aug 12, 2022 | Bunker Kevin D. | Chief Operating Officer | Sell | 5,000 | $30.00 | $150.0K | 95,000 |
| Jul 20, 2022 | Bunker Kevin D. | Chief Operating Officer | Sell | 5,000 | $30.00 | $150.0K | 100,000 |
| Jul 14, 2022 | Bunker Kevin D. | Chief Operating Officer | Sell | 5,000 | $30.01 | $150.1K | 108,290 |
Showing 1–50 of 130
1 / 3
ZNTL Insider Buying Activity
The following table shows recent insider purchases of Zentalis Pharmaceuticals, Inc. (ZNTL) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | WALTERS GROUP | 10% Owner | Buy | 6,459,973 | $1.20 | $7.75M | 0 |
| Apr 30, 2025 | Myers Scott Dunseth | Director | Buy | 21,000 | $1.40 | $29.4K | 0 |
| Feb 12, 2025 | Bruns Ingmar | Chief Medical Officer | Buy | 20,000 | $2.28 | $45.7K | 36,629 |
| Feb 4, 2025 | EASTLAND JULIA MARIE | CEO & President | Buy | 28,500 | $1.73 | $49.3K | 28,500 |
| Feb 4, 2025 | Skvarka Jan | Director | Buy | 60,000 | $1.72 | $103.4K | 149,551 |
| Feb 4, 2025 | Walker Luke Nathaniel | Director | Buy | 14,200 | $1.76 | $25.0K | 86,681 |
| Nov 13, 2023 | Blackwell Kimberly | Chief Executive Officer | Buy | 5,000 | $10.29 | $51.4K | 254,800 |
| Nov 13, 2023 | Johnson David Michael | Director | Buy | 17,000 | $9.88 | $167.9K | 144,389 |
| Jun 20, 2023 | Matrix Capital Management Company, LP | 10% Owner | Buy | 4,760,000 | $22.66 | $107.86M | 13,959,973 |
ZNTL Insider Selling Activity
The following table shows recent insider sales of Zentalis Pharmaceuticals, Inc. (ZNTL) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Bruns Ingmar | officer: Chief Medical Officer | Sell | 3,297 | $2.43 | $8.0K | 33,667 |
| Feb 10, 2026 | EASTLAND JULIA MARIE | director, officer: CEO & President | Sell | 8,755 | $2.43 | $21.2K | 80,022 |
| Feb 10, 2026 | Vultaggio Vincent | officer: PAO and PFO | Sell | 40,224 | $2.43 | $97.6K | 156,779 |
| Feb 6, 2026 | Bruns Ingmar | Chief Medical Officer | Sell | 3,297 | $2.43 | $8.0K | 0 |
| Feb 6, 2026 | EASTLAND JULIA MARIE | CEO & President | Sell | 8,755 | $2.43 | $21.2K | 0 |
| Feb 6, 2026 | Vultaggio Vincent | PAO and PFO | Sell | 40,224 | $2.43 | $97.6K | 0 |
| Feb 4, 2026 | Vultaggio Vincent | officer: PAO and PFO | Sell | 556 | $2.52 | $1.4K | 186,730 |
| Feb 2, 2026 | Vultaggio Vincent | PAO and PFO | Sell | 3,096 | $2.54 | $7.9K | 0 |
| Feb 5, 2025 | Lackner Mark | Chief Scientific Officer | Sell | 14,368 | $1.71 | $24.6K | 512,856 |
| Feb 5, 2025 | Paul Andrea | Chief Legal Officer | Sell | 13,230 | $1.71 | $22.6K | 1,070,784 |
| Feb 5, 2025 | Vultaggio Vincent | PAO and Interim PFO | Sell | 2,615 | $1.71 | $4.5K | 189,826 |
| Jan 3, 2025 | Lackner Mark | Chief Scientific Officer | Sell | 4,411 | $3.12 | $13.8K | 191,317 |
| Oct 4, 2024 | Vultaggio Vincent | Principal Accounting Officer | Sell | 1,603 | $3.18 | $5.1K | 33,855 |
| May 31, 2024 | Gallagher Cam | President, Interim CFO | Sell | 9,597 | $11.98 | $115.0K | 633,680 |
| May 9, 2024 | HAUSMAN DIANA | Chief Medical Officer | Sell | 3,356 | $12.62 | $42.4K | 373,876 |
| Feb 12, 2024 | Epperly Melissa B, | Chief Financial Officer | Sell | 2,573 | $11.44 | $29.4K | 451,449 |
| Feb 12, 2024 | Gallagher Cam | President | Sell | 1,173 | $11.44 | $13.4K | 643,277 |
| Feb 5, 2024 | Epperly Melissa B, | Chief Financial Officer | Sell | 8,669 | $11.54 | $100.0K | 454,022 |
| Feb 5, 2024 | Gallagher Cam | President | Sell | 11,552 | $11.54 | $133.3K | 644,450 |
| Feb 5, 2024 | Lackner Mark | Chief Scientific Officer | Sell | 1,585 | $11.54 | $18.3K | 195,728 |
| Feb 5, 2024 | Paul Andrea | Chief Legal Officer | Sell | 3,310 | $11.54 | $38.2K | 149,973 |
| Oct 6, 2023 | Brownstein Carrie | Chief Medical Officer | Sell | 10,628 | $19.50 | $207.3K | 107,407 |
| Oct 6, 2023 | Bunker Kevin D. | Chief Scientific Officer | Sell | 6,068 | $19.50 | $118.4K | 860,072 |
| Oct 6, 2023 | Epperly Melissa B, | Chief Financial Officer | Sell | 5,482 | $19.50 | $106.9K | 388,579 |
| Sep 13, 2023 | Skvarka Jan | Director | Sell | 5,000 | $25.05 | $125.2K | 47,970 |
| May 31, 2023 | Bunker Kevin D. | Chief Scientific Officer | Sell | 80,000 | $30.02 | $2.40M | 15,000 |
| May 31, 2023 | Gallagher Cam | President | Sell | 27,768 | $26.27 | $729.5K | 482,028 |
| Feb 14, 2023 | Bunker Kevin D. | Chief Scientific Officer | Sell | 10,307 | $20.14 | $207.6K | 871,657 |
| Feb 14, 2023 | Epperly Melissa B, | Chief Financial Officer | Sell | 7,851 | $20.13 | $158.0K | 397,275 |
| Feb 14, 2023 | Gallagher Cam | President | Sell | 11,833 | $20.09 | $237.8K | 499,771 |
| Feb 6, 2023 | Gallagher Cam | President | Sell | 10,000 | $22.27 | $222.7K | 503,675 |
| Jan 18, 2023 | Gallagher Cam | President | Sell | 10,000 | $24.15 | $241.5K | 352,511 |
| Jan 5, 2023 | Gallagher Cam | President | Sell | 10,000 | $21.02 | $210.2K | 362,311 |
| Nov 15, 2022 | Gallagher Cam | President | Sell | 12,500 | $22.77 | $284.7K | 372,911 |
| Nov 8, 2022 | Gallagher Cam | President | Sell | 24,874 | $23.62 | $587.4K | 397,042 |
| Oct 17, 2022 | Gallagher Cam | President | Sell | 12,500 | $23.51 | $293.9K | 409,385 |
| Oct 7, 2022 | Gallagher Cam | President | Sell | 22,500 | $22.45 | $505.2K | 437,381 |
| Sep 16, 2022 | Gallagher Cam | President | Sell | 22,500 | $24.90 | $560.3K | 458,459 |
| Aug 12, 2022 | Bunker Kevin D. | Chief Operating Officer | Sell | 5,000 | $30.00 | $150.0K | 95,000 |
| Jul 20, 2022 | Bunker Kevin D. | Chief Operating Officer | Sell | 5,000 | $30.00 | $150.0K | 100,000 |
| Jul 14, 2022 | Bunker Kevin D. | Chief Operating Officer | Sell | 5,000 | $30.01 | $150.1K | 108,290 |
ZNTL Insiders
EASTLAND JULIA MARIE
director, officer: CEO & President
Bought $49.3KSold $42.5K
3 tradesLast: Feb 10, 2026
Similar Stocks to ZNTL
VRTX
Vertex Pharmaceuticals Incorporated
$457.39-0.09%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$736.34-0.16%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$318.35+2.33%
$42.07B
INSM
Insmed Incorporated
$140.32-2.56%
$30.07B
UTHR
United Therapeutics Corporation
$525.03-0.37%
$23.50B
MRNA
Moderna, Inc.
$51.99-0.63%
$20.76B
ROIV
Roivant Sciences Ltd.
$27.59-0.67%
$20.08B
RPRX
Royalty Pharma plc
$45.27-0.55%
$19.56B